시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 자동 세포 배양 장비 시장 보고서(2025년)
Automated Cell Culture Equipment Global Market Report 2025
상품코드 : 1889306
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,532,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,442,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,352,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

자동 세포 배양 장비 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 20억 7,000만 달러로 평가되었고, 2025년에는 23억 2,000만 달러에 달할 것으로 추정되며, CAGR 12.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 암과 희귀질환 증가, 줄기세포 연구에 대한 수요 증가, 생명공학에 대한 정부 지원 확대, 수탁 연구 기관의 성장, 효율적인 실험실 자동화의 필요성 증가에 의해 견인되어 왔습니다.

자동 세포 배양 장비 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 36억 1,000만 달러에 달할 것으로 예측되며, CAGR 11.7%로 성장할 전망입니다. 예측 기간의 성장은 암 및 희소질환의 유병률 상승, 줄기세포 연구에 대한 수요 증가, 생명공학 분야에 대한 정부 투자 확대, CRO(수탁연구기관)의 지속적인 확대, 합리화된 실험실 자동화의 필요성 증가에 의해 지원될 전망입니다. 예측 기간 동안 예상되는 주요 동향으로는 단일 사용 및 폐쇄 시스템 기술의 혁신, 생물 반응기 및 인큐베이터의 발전, 통합형 세포 처리 플랫폼의 진전, 자동화 워크플로우에 대한 지속적인 조사, 소프트웨어 기반 프로세스 제어 및 모니터링 개선 등이 있습니다.

맞춤형 의료의 도입 확대는 향후 수년간 자동 세포 배양 장비 시장의 성장을 이끌 것으로 예측됩니다. 개인화된 의료는 개인의 유전적 요인, 생활 습관, 환경 요인에 따라 치료를 맞춤화하여 보다 정밀하고 효과적인 치료를 가능하게 합니다. 이 보급 확대는 치료 성과의 향상에 의해 촉진되고 있습니다. 환자의 유전적 및 생물학적 프로파일에 맞춘 치료는 효능을 높여 부작용을 경감할 수 있기 때문입니다. 자동 세포 배양 장비는 정밀하고 높은 처리량, 재현성 있는 세포 배양 공정을 제공함으로써 맞춤형 의료를 지원하고 환자 특이적 치료법의 개발 및 개별화된 약물 시험을 촉진합니다. 예를 들어 2024년 2월 미국 비영리단체 '맞춤형 의료연합'이 발표한 바에 따르면 FDA(미국식품의약품국)는 2023년 희소질환 환자용 신규 맞춤형 치료를 16건 승인하였고 2022년 6건에서 증가했습니다. 맞춤형 의료의 채용 확대는 자동 세포 배양 장비 시장의 성장에 기여하고 있습니다.

자동 세포 배양 장비 시장의 주요 기업은 폐쇄형 단일 사용 소모품 시스템 등 자동화를 통합한 효율적인 워크플로우를 실현하는 기술 혁신에 주력하고 있습니다. 이러한 시스템은 공정을 표준화하고, 오염 위험을 줄이며, 수작업을 최소화하여, 조사 단계에서 임상 제조 단계로 효율적으로 확장할 수 있습니다. 폐쇄형 단일 사용 소모품 시스템은 다중 세포 배양 공정을 단일 단위로 통합한 무균 일회용 장치로 재현성 및 확장성을 갖춘 워크플로우를 보장합니다. 예를 들어 2025년 3월 스위스에 본사를 둔 바이오테크놀러지 기업 Limula SA는 하드웨어 소프트웨어, 일회용 소모품을 통합한 시스템 LimONE을 발표하여 세포 배양 및 처리 워크플로우의 간소화 표준화를 실현했습니다. LimONE은 기술 이전의 가속화, 인건비 및 인프라 비용 절감을 실현하여 CAR-T 요법과 유전자 편집 줄기 세포를 포함한 첨단 세포 치료의 확장 가능한 생산을 가능하게 합니다. 동시에 재현성 및 규제 준수를 확보합니다. 이 제품의 출시로 Limula는 자동 세포 배양 장비 시장에서의 지위를 강화했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Automated cell culture equipment refers to advanced laboratory systems designed to perform cell cultivation, maintenance, and monitoring with minimal human involvement. These systems incorporate technologies such as robotics, sensors, and software to improve reproducibility, efficiency, and precision in cell culture workflows. By automating routine processes, they enable high-throughput experimentation, lower the risk of contamination, and support complex research in drug development, regenerative medicine, and other life science fields.

The main product types of automated cell culture equipment include instruments, consumables, and software. Instruments refer to advanced laboratory devices used to automate essential cell culture steps such as seeding, incubation, monitoring, and harvesting, enhancing consistency, efficiency, and scalability. These systems function at different automation levels, including fully automated systems, semi-automated systems, and manual systems with automated features. Key applications include drug discovery and development, regenerative medicine, toxicology testing, vaccine development, and stem cell research. Primary end users include pharmaceutical companies, biotechnology companies, academic and research institutions, contract research organizations (CROs), and diagnostics and testing laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The automated cell culture equipment market research report is one of a series of new reports from The Business Research Company that provides automated cell culture equipment market statistics, including the automated cell culture equipment industry global market size, regional shares, competitors with the automated cell culture equipment market share, detailed automated cell culture equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the automated cell culture equipment industry. This automated cell culture equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The automated cell culture equipment market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. Growth in the historic period was driven by the increasing prevalence of cancer and rare diseases, rising demand for stem cell research, expanding government support for biotechnology, growth of contract research organizations, and the growing need for efficient laboratory automation.

The automated cell culture equipment market size is expected to see rapid growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. Growth in the forecast period will be supported by the rising prevalence of cancer and rare diseases, increasing demand for stem cell research, greater government investment in biotechnology, continued expansion of contract research organizations, and a growing need for streamlined laboratory automation. Major trends expected in the forecast period include innovations in single-use and closed system technologies, advancements in bioreactors and incubators, progress in integrated cell processing platforms, ongoing research in automated workflows, and improvements in software-driven process control and monitoring.

The growing adoption of personalized medicine is expected to drive the growth of the automated cell culture equipment market in the coming years. Personalized medicine customizes medical treatment based on an individual's genetic, lifestyle, and environmental factors, enabling more precise and effective care. This rising adoption is fueled by improved treatment outcomes, as therapies tailored to a patient's genetic and biological profile can enhance efficacy and reduce adverse effects. Automated cell culture equipment supports personalized medicine by providing precise, high-throughput, and reproducible cell culture processes, facilitating the development of patient-specific therapies and tailored drug testing. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, up from six in 2022. This growth in personalized medicine adoption is contributing to the expansion of the automated cell culture equipment market.

Key companies in the automated cell culture equipment market are focusing on innovations that integrate automation for streamlined workflows, such as closed single-use consumable systems. These systems standardize processes, reduce contamination risks, minimize manual handling, and enable efficient scaling from research to clinical manufacturing. A closed single-use consumable system is a sterile, disposable setup that integrates multiple cell culture processes into one unit, ensuring reproducible and scalable workflows. For instance, in March 2025, Limula SA, a Switzerland-based biotechnology company, launched LimONE, an integrated system combining hardware, software, and single-use consumables to simplify and standardize cell culture and processing workflows. LimONE supports faster technology transfer, lowers labor and infrastructure costs, and enables scalable production of advanced cell therapies, including CAR-T and gene-edited stem cells, while ensuring reproducibility and regulatory compliance. This product launch strengthens Limula's position in the automated cell culture equipment market.

In August 2023, Cell Microsystems, a U.S.-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. The acquisition allows Cell Microsystems to expand its portfolio of advanced cell analysis solutions by integrating Fluxion Biosciences' automated patch clamp and cell-based assay technologies, enhancing capabilities for cellular electrophysiology and rare cell research. Fluxion Biosciences specializes in automated patch clamp technology and cell-based assay tools for advanced cellular analysis.

Major companies operating in the automated cell culture equipment market are F. Hoffmann-La Roche Ltd, Hitachi Ltd., Merck KGaA, Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Olympus Corporation, Sartorius AG, Eppendorf SE, Tecan Group Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Greiner Bio-One International GmbH, Solida Biotech GmbH, Biostream International B.V., HiMedia Laboratories Pvt. Ltd., Kuhner Shaker AG, Cellexus International Ltd.

North America was the largest region in the automated cell culture equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in automated cell culture equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the automated cell culture equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The automated cell culture equipment market consists of sales of automated cell culture systems, bioreactors, incubators, cell counters, liquid handling systems, cell imaging systems, consumables, reagents, culture plates, flasks, pipettes, tubing sets, sensors, and microcarriers. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automated Cell Culture Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on automated cell culture equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for automated cell culture equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated cell culture equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Automated Cell Culture Equipment Market Characteristics

3. Automated Cell Culture Equipment Market Trends And Strategies

4. Automated Cell Culture Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Automated Cell Culture Equipment Growth Analysis And Strategic Analysis Framework

6. Automated Cell Culture Equipment Market Segmentation

7. Automated Cell Culture Equipment Market Regional And Country Analysis

8. Asia-Pacific Automated Cell Culture Equipment Market

9. China Automated Cell Culture Equipment Market

10. India Automated Cell Culture Equipment Market

11. Japan Automated Cell Culture Equipment Market

12. Australia Automated Cell Culture Equipment Market

13. Indonesia Automated Cell Culture Equipment Market

14. South Korea Automated Cell Culture Equipment Market

15. Western Europe Automated Cell Culture Equipment Market

16. UK Automated Cell Culture Equipment Market

17. Germany Automated Cell Culture Equipment Market

18. France Automated Cell Culture Equipment Market

19. Italy Automated Cell Culture Equipment Market

20. Spain Automated Cell Culture Equipment Market

21. Eastern Europe Automated Cell Culture Equipment Market

22. Russia Automated Cell Culture Equipment Market

23. North America Automated Cell Culture Equipment Market

24. USA Automated Cell Culture Equipment Market

25. Canada Automated Cell Culture Equipment Market

26. South America Automated Cell Culture Equipment Market

27. Brazil Automated Cell Culture Equipment Market

28. Middle East Automated Cell Culture Equipment Market

29. Africa Automated Cell Culture Equipment Market

30. Automated Cell Culture Equipment Market Competitive Landscape And Company Profiles

31. Automated Cell Culture Equipment Market Other Major And Innovative Companies

32. Global Automated Cell Culture Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Automated Cell Culture Equipment Market

34. Recent Developments In The Automated Cell Culture Equipment Market

35. Automated Cell Culture Equipment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기